Zhongming Zhao Selected Research

Drug Combinations

2/2022	Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence.
11/2021	Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence.
12/2020	Drug Repurposing for COVID-19 using Graph Neural Network with Genetic, Mechanistic, and Epidemiological Validation.
1/2017	Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhongming Zhao Research Topics

Disease

107	Neoplasms (Cancer) 03/2024 - 06/2010
17	Schizophrenia (Dementia Praecox) 05/2023 - 12/2009
15	Carcinogenesis 01/2023 - 01/2011
11	Lung Neoplasms (Lung Cancer) 01/2018 - 03/2012
9	COVID-19 12/2023 - 01/2020
9	Glioblastoma (Glioblastoma Multiforme) 06/2023 - 01/2011
7	Breast Neoplasms (Breast Cancer) 04/2023 - 01/2011
6	Melanoma (Melanoma, Malignant) 06/2023 - 09/2012
6	Prostatic Neoplasms (Prostate Cancer) 03/2023 - 01/2009
5	Fibrosis (Cirrhosis) 08/2023 - 08/2011
5	Infections 01/2023 - 01/2021
4	Cardiomyopathies (Cardiomyopathy) 04/2024 - 01/2021
4	Hypoxia (Hypoxemia) 02/2024 - 12/2016
4	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 12/2020
4	Mental Disorders (Mental Disorder) 05/2023 - 01/2011
4	Alcoholism (Alcohol Abuse) 01/2018 - 01/2009
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 03/2012
3	Wounds and Injuries (Trauma) 04/2024 - 03/2023
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 01/2012
3	Triple Negative Breast Neoplasms 04/2023 - 10/2021
3	Inflammation (Inflammations) 02/2023 - 09/2010
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2020
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 12/2013
3	Tobacco Use Disorder (Nicotine Dependence) 01/2020 - 10/2016
3	Heart Failure 01/2020 - 01/2013
3	Adenocarcinoma 12/2018 - 01/2013
3	Neoplasm Metastasis (Metastasis) 11/2017 - 01/2009
3	Neurocognitive Disorders (Clerambault Syndrome) 06/2017 - 04/2016
2	Multiple Sclerosis 04/2024 - 11/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 01/2023
2	Cognitive Dysfunction 01/2024 - 09/2023
2	Adenocarcinoma of Lung 12/2023 - 05/2014
2	Myocardial Infarction 10/2023 - 01/2013
2	Glioma (Gliomas) 06/2023 - 01/2022
2	Major Depressive Disorder (Major Depressive Disorders) 05/2023 - 01/2011
2	Bipolar Disorder (Manic Depressive Psychosis) 05/2023 - 11/2017
2	Bites and Stings (Sting) 01/2023 - 01/2021
2	Thrombosis (Thrombus) 01/2023 - 10/2022
2	Carcinoma (Carcinomatosis) 06/2022 - 10/2017
2	Amelogenesis Imperfecta 01/2022 - 02/2021
2	Obesity 01/2022 - 12/2017
2	Fatty Liver 01/2022 - 01/2022
2	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 01/2013
2	Seminoma 01/2021 - 01/2020
2	Lung Injury 01/2021 - 01/2020
2	Cleft Palate (Palate, Cleft) 01/2020 - 01/2018
2	Weight Gain 01/2018 - 10/2014
2	Thyroid Neoplasms (Thyroid Cancer) 01/2018 - 11/2010
2	Body Weight (Weight, Body) 12/2017 - 01/2012

Drug/Important Bio-Agent (IBA)

34	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2010
32	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2012
31	MicroRNAs (MicroRNA)IBA 05/2022 - 02/2010
17	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2009
16	Transcription Factors (Transcription Factor)IBA 11/2023 - 02/2010
14	Messenger RNA (mRNA)IBA 01/2023 - 11/2010
10	Phosphotransferases (Kinase)IBA 01/2021 - 11/2010
7	Long Noncoding RNAIBA 09/2020 - 01/2015
6	Tyrosine Kinase InhibitorsIBA 01/2018 - 09/2013
5	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 11/2010
5	ChromatinIBA 03/2023 - 11/2010
4	NucleotidesIBA 04/2024 - 01/2013
4	Drug CombinationsIBA 02/2022 - 01/2017
4	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2009
4	LigandsIBA 01/2022 - 09/2015
4	ProteomeIBA 01/2022 - 12/2016
4	Antipsychotic Agents (Antipsychotics)IBA 10/2014 - 01/2011
3	HydrogelsIBA 04/2024 - 10/2023
3	CateninsIBA 08/2023 - 01/2011
3	Epidermal Growth Factor (EGF)IBA 01/2023 - 06/2010
3	Estrogen ReceptorsIBA 01/2023 - 12/2016
3	Genetic Markers (Genetic Marker)IBA 01/2023 - 01/2011
3	CarcinogensIBA 01/2022 - 12/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
3	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 03/2012
3	Small Interfering RNA (siRNA)IBA 01/2021 - 11/2010
2	Apolipoproteins E (ApoE)IBA 01/2024 - 09/2023
2	Small Nuclear RNA (snRNA)IBA 01/2024 - 09/2023
2	Desmoplakins (Desmoplakin)IBA 08/2023 - 02/2023
2	KynurenineIBA 05/2023 - 05/2023
2	TransposasesIBA 03/2023 - 01/2023
2	InterferonsIBA 01/2023 - 01/2022
2	Antiviral Agents (Antivirals)IBA 01/2023 - 12/2021
2	AnticoagulantsIBA 01/2023 - 10/2022
2	Insulin (Novolin)FDA Link 01/2022 - 03/2012
2	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2018
2	Circular RNAIBA 06/2021 - 10/2017
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 11/2020
2	Cocaine (Cocaine HCl)IBA 01/2020 - 01/2018
2	SmokeIBA 01/2020 - 10/2016
2	IntegrinsIBA 02/2019 - 01/2017
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 02/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2016 - 09/2012

Therapy/Procedure

38	Therapeutics 02/2024 - 09/2012
7	Immunotherapy 03/2024 - 01/2021
3	Drug Therapy (Chemotherapy) 01/2023 - 09/2020
3	Precision Medicine 01/2023 - 01/2014
3	Oncolytic Virotherapy 06/2022 - 01/2021
3	Highly Active Antiretroviral Therapy (HAART) 06/2017 - 01/2014
2	Radiotherapy 06/2023 - 12/2020
2	Aftercare (After-Treatment) 01/2022 - 03/2012